CAR-T Cell Therapy Resource Center
News & Information for Healthcare Professionals
CAR T-Cell Therapy HCP Guide – The Costs Involved in CAR T-Cell Therapy
Costs and Payer Questions
A patient-specific and complicated manufacturing process such as CAR T is expected to be costly. The cost of the first...
The state of cancer: Are we close to a cure?
March 2, 2018 (Medical News Today)
At present, the most common types of treatment for cancer – the leading cause of death – are chemotherapy,...
Immunotherapy for Glioblastoma: On the Sidelines or in the Game?
November 28, 2017 (Discovery Medicine)
Glioblastoma remains a major unmet medical need in the field of oncology. With less than 10% of patients surviving five...
Cancer: How a novel gel could halt its return
March 23, 2018 (Medical News Today)
A biodegradable gel has been developed to stop the recurrence of cancer. Scientists at the Dana-Farber Cancer Institute in...
VIDEO: CAR T-cells for CLL
February 19, 2018 (YouTube) Constantine Tam, MD, FRACP, FRCPA, of Peter MacCallum Cancer Centre, Melbourne, Australia.
Speaking from the American Society of Hematology (ASH) 2017...
VIDEO: The Impact of CAR T-Cell Therapy on ALL
February 15, 2018 (YouTube)
Alexander E. Perl, MD, associate professor of medicine, University of Pennsylvania, discusses the impact of CAR T-cell therapy for patients with...
Gene Tx Approved for Certain Types of B-Cell Lymphoma
October 19, 2017 (HealthDay News)
Yescarta (axicabtagene ciloleucel) has been approved by the U.S. Food and Drug Administration for individuals with certain types of...
Cancer: Some immune cells found to give tumors a helping hand
December 13, 2017 (Medical News Today)
Lung cancer is the most common cause of cancer-related deaths worldwide. It is the second most common cancer...
Neurotoxicity Characterized After Infusion of CD19 CAR-T Cells
October 12, 2017 (HealthDay News)
Patients with severe neurotoxicity after infusion of CD19-targeted chimeric antigen receptor-modified T (CAR-T) cells have evidence of endothelial activation,...
Axi-Cel and Future of CAR T-Cell Therapy in Lymphoma
Published on February 13, 2018
Sattva S. Neelapu, MD, discusses the safety and practical implications for axi-cel (KTE-C19) as part of the ZUMA-1 trial, as...
